Skip to main content

Table 7 In vitro individual risk of bias

From: Comprehensive preclinical studies on the bioactivity of Orbignya phalerata Mart. (Babassu) and its derived products: a systematic review

  1. Questions: Q1—cells/strains from validated repository or appropriately verified; Q2—technical repeats and controls inclusion; Q3—use of different cell lines/strains/reactions; Q4—comparable conditions between groups/assays; Q5—selective outcome reporting; Q6—comparison of different cell lines/strains/substances. Total: 102 (100%); (+) Yes: 67 (65.69%); (−) No: 8 (7.84%); (?) Unclear: 7 (6.86%); () Not applicable: 20 (19.61%). Questions adapted from Lewis et al. [20]